Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Chris Lange | Oct 21, 2018 at 10:15 AM EDT

Top Biotech Earnings Reports to Watch This Week

Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming…

Chris Lange | Oct 11, 2018 at 1:20 PM EDT

How Compugen Is Weathering Thursday’s Storm

Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 27, 2018 at 7:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Jon C. Ogg | Aug 22, 2018 at 11:10 AM EDT

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team…

Chris Lange | Aug 10, 2018 at 9:50 AM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 7, 2018 at 1:00 PM EDT

The Next 15 Companies Set to Join the $100 Billion Market Cap Club

Here are the 15 companies that appear most likely to enter or get back into the $100 billion market capitalization…

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 22, 2018 at 10:25 AM EDT

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger…

Lee Jackson | Jul 20, 2018 at 8:00 AM EDT

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Four pharmaceutical industry leaders are poised to report second-quarter results next week, and one key analyst sees the relatively good…

Chris Lange | Jul 12, 2018 at 8:50 AM EDT

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jun 27, 2018 at 1:05 PM EDT

Short Sellers Hike Bets in Major Pharma Stocks

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jun 12, 2018 at 10:49 AM EDT

Major Pharmaceuticals Scare Off Short Sellers

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay…

1 … 14 15 16 17 18 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Biotech Earnings Reports to Watch This Week

How Compugen Is Weathering Thursday’s Storm

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Short Sellers Hike Bets in Major Pharma Stocks

The Next 15 Companies Set to Join the $100 Billion Market Cap Club

Major Pharma Stocks Scare Off Short Sellers

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Where Did Major Pharma Short Sellers Go?

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharmaceuticals Scare Off Short Sellers

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Top Biotech Earnings Reports to Watch This Week

How Compugen Is Weathering Thursday’s Storm

Short Sellers Run for Cover From Major Pharma

Short Sellers Grow More Selective on Major Pharma Stocks

Short Sellers Back Off Major Pharma Stocks

Short Sellers Can’t Make Up Their Minds on Major Pharma Stocks

Why Big Pharma Stocks May Offer Big Upside and Dividends for the Second Half of 2018

Short Sellers Hike Bets in Major Pharma Stocks

The Next 15 Companies Set to Join the $100 Billion Market Cap Club

Major Pharma Stocks Scare Off Short Sellers

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

Top Analyst Bullish on Big Pharmaceutical Stocks Before Q2 Earnings

Where Did Major Pharma Short Sellers Go?

Short Sellers Hike Bets in Major Pharma Stocks

Major Pharmaceuticals Scare Off Short Sellers

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It